How to use this to enhance B cells and follistatin related diseases, conditions, disorders, and as well as to increase the growth and strength of muscle

摘要

The present invention relates to methods for administering autologous and / or allogeneic B cells genetically modified to produce therapeutic agents such as follistatin.A method for administering gene modified B cells of a single maximum effective dose and a method for administering gene modified B cells expressing a plurality of doses of folistatin are specifically disclosed.The compositions and methods disclosed herein are useful for long-term in vivo delivery of follistatin.